Unlocking The Human Urobiome: Impact On Health and Disease- A Review
Life Sciences-Microbiology
DOI:
https://doi.org/10.22376/ijlpr.2023.13.1.L81-95Keywords:
Human Microbiome, Microbiota, Urobiome, 16S rRNA Sequencing, Dysbiosis, Viromes, and, BacteriophagesAbstract
The urinary microbiome or the urobiome are the group of microbes present in the urinary tract. They came into the limelight in the last decade due to advances in diagnostic technologies. Two complementary assays are widely used for research in urobiomes. Next-generation sequencing (NGS) of 16S ribosomal RNA (rRNA) paired with enhanced urine culture techniques (EUCT) are widely employed for research. This has paved the way for investigations on sterile body sites such as urine thereby breaking the myth of urine being considered sterile. EUCT, such as expanded quantitative urine culture (EQUC) contributed to the evidence that the microbes detected by the NGS are still alive. EQUC has been employed in clinical laboratories since the last decade and is indicated only when there are unexplained clinical symptoms and conventional urine culture is negative. Our aim is to have a comprehensive review study on the urobiome concerning health, its association with urological pathologies. Our main objective is to collect review and research articles using databases and review them for obtaining in-depth knowledge of the urobiome as well as to identify possible alternate study areas. The urobiome is a new area with minimal information available. This review helps the researcher to comprehend this upcoming area easily. Investigations into urobiome research, however, could have a considerable impact on our understanding of the pathogenesis of urogenital disorders and even reveal novel possibilities. Thus, the forthcoming years will open a ripe ground for future research into diagnosis, treatment and prevention strategies for urological pathologies.
References
Banerjee S, Robertson ES Chapter 17. Future perspectives: microbiome, Cancer and Therapeutic Promise. In: Robertson ES, editor. Microbiome and Cancer. New York: Humana Press; 2019:363-89. doi: 10.1007/978-3-030-04155-7_17.
Thomas-White K, Brady M, Wolfe AJ, Mueller ER. The bladder is not sterile: history and current discoveries on the urinary microbiome. Curr Bladder Dysfunct Rep. 2016;11(1):18-24. doi: 10.1007/s11884-016-0345-8, PMID 27182288.
Handelsman J. Metagenomics: application of genomics to uncultured microorganisms. Microbiol Mol Biol Rev. 2004;68(4):669-85. doi: 10.1128/MMBR.68.4.669-685.2004, PMID 15590779.
Wooley JC, Godzik A, Friedberg I. A primer on metagenomics. PLOS Comput Biol. 2010;6(2):e1000667. doi: 10.1371/journal.pcbi.1000667, PMID 20195499.
NIH HMP Working Group, Peterson J, Garges S, Giovanni M, McInnes P, Wang L et al. The NIH human microbiome project. Genome Res. 2009;19(12):2317-23. doi: 10.1101/gr.096651.109, PMID 19819907.
Hilt EE, McKinley K, Pearce MM, Rosenfeld AB, Zilliox MJ, Mueller ER et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol. 2014;52(3):871-6. doi: 10.1128/JCM.02876-13, PMID 24371246.
Whiteside SA, Razvi H, Dave S, Reid G, Burton JP. The microbiome of the urinary tract–a role beyond infection. Nat Rev Urol. 2015;12(2):81-90. doi: 10.1038/nrurol.2014.361, PMID 25600098.
Morand A, Cornu F, Dufour JC, Tsimaratos M, Lagier JC, Raoult D. Human bacterial repertoire of the urinary tract: a potential paradigm shift. J Clin Microbiol. 2019;57(3):675. doi: 10.1128/JCM.00675-18, PMID 30404941.
Gerges-Knafl D, Pichler P, Zimprich A, Hotzy C, Barousch W, Lang RM et al. The urinary microbiome shows different bacterial genera in renal transplant recipients and non-transplant patients at time of acute kidney injury – a pilot study. BMC Nephrol. 2020;21(1):117. doi: 10.1186/s12882-020-01773-1, PMID 32252662.
Ursell LK, Metcalf JL, Parfrey LW, Knight R. Defining the human microbiome. Nutr Rev. 2012 Aug;70 Suppl 1(Suppl 1):S38-44. doi: 10.1111/j.1753-4887.2012.00493.x. PMID: 22861806; PMCID: PMC3426293.
Ackerman AL, Underhill DM. The mycobiome of the human urinary tract: potential roles for fungi in urology. Ann Transl Med. 2017;5(2):31. doi: 10.21037/atm.2016.12.69, PMID 28217696.
Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015 May;13(5):269-84. doi: 10.1038/nrmicro3432, PMID 25853778.
Wolfe AJ, Brubaker L. Urobiome updates: advances in urinary microbiome research. Nat Rev Urol. 2019;16(2):73-4. doi: 10.1038/s41585-018-0127-5, PMID 30510275.
Wolfe AJ, Toh E, Shibata N, Rong R, Kenton K, Fitzgerald M et al. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol. 2012;50(4):1376-83. doi: 10.1128/JCM.05852-11, PMID 22278835.
Lukacz ES, Bavendam TG, Berry A, Fok CS, Gahagan S, Goode PS et al. A novel research definition of bladder health in women and girls: implications for research and public health promotion. J Womens Health (Larchmt). 2018;27(8):974-81. doi: 10.1089/jwh.2017.6786, PMID 29792542.
Mueller ER, Wolfe AJ, Brubaker L. Female urinary microbiota. Curr Opin Urol. 2017;27(3):282-6. doi: 10.1097/MOU.0000000000000396, PMID 28234750.
Gottschick C, Deng ZL, Vital M, Masur C, Abels C, Pieper DH et al. The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment. Microbiome. 2017;5(1):99. doi: 10.1186/s40168-017-0305-3, PMID 28807017.
Fouts DE, Pieper R, Szpakowski S, Pohl H, Knoblach S, Suh MJ et al. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med. 2012;10:174. doi: 10.1186/1479-5876-10-174, PMID 22929533.
Siddiqui H, Nederbragt AJ, Lagesen K, Jeansson SL, Jakobsen KS. Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol. 2011;11:244. doi: 10.1186/1471-2180-11-244, PMID 22047020.
Lewis DA, Brown R, Williams J, White P, Jacobson SK, Marchesi JR et al. The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Front Cell Infect Microbiol. 2013;3:41. doi: 10.3389/fcimb.2013.00041, PMID 23967406.
Wojciuk B, Salabura A, Grygorcewicz B, Kędzierska K, Ciechanowski K, Dołegowska B. Urobiome: in sickness and in health. Microorganisms. 2019;7(11):548. doi: 10.3390/microorganisms7110548, PMID 31717688.
Evenepoel P, Poesen R, Meijers B. The gut–kidney axis. Pediatr Nephrol. 2017;32(11):2005-14. doi: 10.1007/s00467-016-3527-x, PMID 27848096.
Lee JA, Stern JM. Understanding the link between gut microbiome and urinary stone disease. Curr Urol Rep. 2019;20(5):19. doi: 10.1007/s11934-019-0882-8, PMID 30903295.
Borges S, Silva J, Teixeira P. The role of lactobacilli and probiotics in maintaining vaginal health. Arch Gynecol Obstet. 2014;289(3):479-89. doi: 10.1007/s00404-013-3064-9, PMID 24170161.
Allsworth JE, Lewis VA, Peipert JF. Viral sexually transmitted infections and bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Sex Transm Dis. 2008;35(9):791-6. doi: 10.1097/OLQ.0b013e3181788301, PMID 18607314.
Gajer P, Brotman RM, Bai G, Sakamoto J, Schütte UM, Zhong X, et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012;4(132):132ra52. doi: 10.1126/scitranslmed.3003605, PMID 22553250.
Rodriguez D, Goulart C, Pagliarone AC, Silva EP, Cunegundes PS, Nascimento IP et al. In vitro evidence of human immune responsiveness shows the improved potential of a recombinant BCG strain for bladder cancer treatment. Front Immunol. 2019;10:1460. doi: 10.3389/fimmu.2019.01460, PMID 31297119.
Mulder M, Radjabzadeh D, Hassing RJ, Heeringa J, Uitterlinden AG, Kraaij R et al. The effect of antimicrobial drug use on the composition of the genitourinary microbiota in an elderly population. BMC Microbiol. 2019;19(1):9. doi: 10.1186/s12866-018-1379-1, PMID 30626324.
Wu P, Zhang G, Zhao J, Chen J, Chen Y, Huang W et al. Corrigendum: profiling the urinary microbiota in male patients with bladder cancer in China. Front Cell Infect Microbiol. 2018;8:429. doi: 10.3389/fcimb.2018.00429, PMID 30588456.
Bučević Popović V, Šitum M, Chow CT, Chan LS, Roje B, Terzić J. The urinary microbiome associated with bladder cancer. Sci Rep. 2018;8(1):12157. doi: 10.1038/s41598-018-29054-w, PMID 30108246.
Nelson DE, Van Der Pol B, Dong Q, Revanna KV, Fan B, Easwaran S et al. Characteristic male urine microbiomes associate with asymptomatic sexually transmitted infection. PLOS ONE. 2010;5(11):e14116. doi: 10.1371/journal.pone.0014116.
Komesu YM, Richter HE, Carper B, Dinwiddie DL, Lukacz ES, Siddiqui NY et al. The urinary microbiome in women with mixed urinary incontinence compared to similarly aged controls. Int Urogynecol J. 2018;29(12):1785-95. doi: 10.1007/s00192-018-3683-6, PMID 29909556.
Armbruster CE, Mobley HLT, Pearson MM. Pathogenesis of Proteus mirabilis infection. EcoSal Plus. 2018 Feb;8(1). doi: 10.1128/ecosalplus.ESP-0009-2017, PMID 29424333.
Coker C, Poore CA, Li X, Mobley HLT. Pathogenesis of Proteus mirabilis urinary tract infection. Microbes Infect. 2000;2(12):1497-505. doi: 10.1016/s1286-4579(00)01304-6, PMID 11099936.
Kline KA, Lewis AL. Gram-positive uropathogens, polymicrobial urinary tract infection, and the emerging microbiota of the urinary tract. Microbiol Spectr. 2016 Apr;4(2). doi: 10.1128/microbiolspec.UTI-0012-2012, PMID 27227294.
Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28(1):1-13. doi: 10.1016/j.idc.2013.09.003, PMID 24484571.
Magruder M, Sholi AN, Gong C, Zhang L, Edusei E, Huang J, et al. Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection. Nat Commun. 2019;10(1):5521. doi: 10.1038/s41467-019-13467-w, PMID 31797927.
Thänert R, Reske KA, Hink T, Wallace MA, Wang B, Schwartz DJ, et al. Comparative genomics of antibiotic-resistant uropathogens implicates three routes for recurrence of urinary tract infections. mBio. 2019;10(4):e01977-19. doi: 10.1128/mBio.01977-19, PMID 31455657.
Navas-Nacher EL, Dardick F, Venegas MF, Anderson BE, Schaeffer AJ, Duncan JL. Relatedness of Escherichia coli colonizing women longitudinally. Mol Urol. 2001;5(1):31-6. doi: 10.1089/109153601750124285, PMID 11689149.
Lewis AL, Gilbert NM. Roles of the vagina and the vaginal microbiota in urinary tract infection: evidence from clinical correlations and experimental models. GMS Infect Dis. 2020;8:Doc02. doi: 10.3205/id000046, PMID 32373427.
Sumati AH, Saritha NK. Association of urinary tract infection in women with bacterial vaginosis. J Glob Infect Dis. 2009;1(2):151-2. doi: 10.4103/0974-777X.56254, PMID 20300409.
Gilbert NM, O’Brien VP, Lewis AL. Transient microbiota exposures activate dormant Escherichia coli infection in the bladder and drive severe outcomes of recurrent disease. PLOS Pathog. 2017;13(3):e1006238. doi: 10.1371/journal.ppat.1006238.
Muhleisen AL, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas. 2016;91:42-50. doi: 10.1016/j.maturitas.2016.05.015, PMID 27451320.
Mirmonsef P, Gilbert D, Zariffard MR, Hamaker BR, Kaur A, Landay AL et al. The effects of commensal bacteria on innate immune responses in the female genital tract. Am J Reprod Immunol. 2011;65(3):190-5. doi: 10.1111/j.1600-0897.2010.00943.x, PMID 21143335.
Naboka IuL, Kogan MI, Vasil’eva LI, Gudima IA, Miroshnichenko EA, Ibishev KhS. Bacterial mixed infection in women with chronic recurrent cystitis. Zh Mikrobiol Epidemiol Immunobiol. 2011;1(1):8-12. PMID 21446162.
Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011;52(10):1212-7. doi: 10.1093/cid/cir183, PMID 21498386.
Rupp ME, Soper DE, Archer GL. Colonization of the female genital tract with Staphylococcus saprophyticus. J Clin Microbiol. 1992;30(11):2975-9. doi: 10.1128/jcm.30.11.2975-2979.1992, PMID 1452668.
Hovelius B, Colleen S, Mårdh PA. Urinary tract infections in men caused by Staphylococcus saprophyticus. Scand J Infect Dis. 1984;16(1):37-41. doi: 10.3109/00365548409068407, PMID 6695157.
Zong Z, Peng C, Lü X. Diversity of SCCmec elements in methicillin-resistant coagulase-negative staphylococci clinical isolates. PLOS ONE. 2011;6(5):e20191. doi: 10.1371/journal.pone.0020191. PMID 21637845.
Kleine B, Gatermann S, Sakinc T. Genotypic and phenotypic variation among Staphylococcus saprophyticus from human and animal isolates. BMC Res Notes. 2010;3:163. doi: 10.1186/1756-0500-3-163, PMID 20537181.
Gatermann S, Kreft B, Marre R, Wanner G. 1992. Identification and characterization of a surface-associated protein (Ssp) of Staphylococcus saprophyticus. Infect Immun 60:1055–1060.
Kuroda M, Yamashita A, Hirakawa H, Kumano M, Morikawa K, Higashide M et al. Whole genome sequence of Staphylococcus saprophyticus reveals the pathogenesis of uncomplicated urinary tract infection. Proc Natl Acad Sci U S A. 2005;102(37):13272-7. doi: 10.1073/pnas.0502950102, PMID 16135568.
King NP, Sakinç T, Ben Zakour NL, Totsika M, Heras B, Simerska P et al. Characterisation of a cell wall-anchored protein of Staphylococcus saprophyticus associated with linoleic acid resistance. BMC Microbiol. 2012;12:8. doi: 10.1186/1471-2180-12-8, PMID 22243671.
Schneewind O, Missiakas DM. Protein secretion and surface display in Gram-positive bacteria. Philos Trans R Soc Lond B Biol Sci. 2012;367(1592):1123-39. doi: 10.1098/rstb.2011.0210, PMID 22411983.
Fowler JE Jr. Staphylococcus saprophyticus as the cause of infected urinary calculus. Ann Intern Med. 1985;102(3):342-3. doi: 10.7326/0003-4819-102-3-342, PMID 3871598.
Sakinç T, Michalski N, Kleine B, Gatermann SG. The uropathogenic species Staphylococcus saprophyticus tolerates a high concentration of D-serine. FEMS Microbiol Lett. 2009;299(1):60-4. doi: 10.1111/j.1574-6968.2009.01731.x, PMID 19674114.
Gilbert NM, O’Brien VP, Hultgren S, Macones G, Lewis WG, Lewis AL. Urinary tract infection as a preventable cause of pregnancy complications: opportunities, challenges, and a global call to action. Glob Adv Health Med. 2013;2(5):59-69. doi: 10.7453/gahmj.2013.061, PMID 24416696.
Remy L, Carrière M, Derré-Bobillot A, Martini C, Sanguinetti M, Borezée-Durant E. The Staphylococcus aureus Opp1 ABC transporter imports nickel and cobalt in zinc-depleted conditions and contributes to virulence. Mol Microbiol. 2013;87(4):730-43. doi: 10.1111/mmi.12126, PMID 23279021.
Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29(11):996-1011. doi: 10.1086/591861, PMID 18947320.
Carton JA, Maradona JA, Nuño FJ, Fernandez-Alvarez R, Pérez-Gonzalez F, Asensi V. Diabetes mellitus and bacteraemia: A comparative study between diabetic and non-diabetic patients. Eur J Med. 1992;1(5):281-7. PMID 1341610.
Bonadio M, Costarelli S, Morelli G, Tartaglia T. The influence of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in elderly adult patients with urinary tract infection. BMC Infect Dis. 2006;6:54. doi: 10.1186/1471-2334-6-54, PMID 16545130.
Tendolkar PM, Baghdayan AS, Gilmore MS, Shankar N. Enterococcal surface protein, Esp, enhances biofilm formation by Enterococcus faecalis. Infect Immun. 2004;72(10):6032-9. doi: 10.1128/IAI.72.10.6032-6039.2004, PMID 15385507.
Nielsen HV, Guiton PS, Kline KA, Port GC, Pinkner JS, Neiers F et al. The metal ion-dependent adhesion site motif of the Enterococcus faecalis EbpA pilin mediates pilus function in catheter-associated urinary tract infection. mBio. 2012;3(4):e00177-12. doi: 10.1128/mBio.00177-12, PMID 22829678.
Torelli R, Serror P, Bugli F, Paroni Sterbini F, Florio AR, Stringaro A et al. The PavA-like fibronectin-binding protein of Enterococcus faecalis, EfbA, is important for virulence in a mouse model of ascending urinary tract infection. J Infect Dis. 2012;206(6):952-60. doi: 10.1093/infdis/jis440, PMID 22782954.
Chaiwarith R, Jullaket W, Bunchoo M, Nuntachit N, Sirisanthana T, Supparatpinyo K. Streptococcus agalactiae in adults at Chiang Mai University Hospital: a retrospective study. BMC Infect Dis. 2011;11:149. doi: 10.1186/1471-2334-11-149, PMID 21612629.
Kessous R, Weintraub AY, Sergienko R, Lazer T, Press F, Wiznitzer A et al. Bacteruria with group-B streptococcus: is it a risk factor for adverse pregnancy outcomes? J Matern Fetal Neonatal Med. 2012;25(10):1983-6. doi: 10.3109/14767058.2012.671872, PMID 22530608.
Verani JR, McGee L, Schrag SJ, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1-36. PMID 21088663.
Kline KA, Schwartz DJ, Lewis WG, Hultgren SJ, Lewis AL. Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection. Infect Immun. 2011;79(9):3588-95. doi: 10.1128/IAI.00122-11, PMID 21690238.
Tambyah PA, Maki DG. Catheter- associated urinary tract infection is rarely symp- tomatic: A prospective study of 1,497 catheterized patients. Arch Intern Med. 2000;160(5):678-82. doi: 10.1001/archinte.160.5.678, PMID 10724054.
Lewis K. Multidrug tolerance of biofilms and persister cells. Curr Top Micro- biol Immunol. 2008;322:107-31.
Kline KA, Ingersoll MA, Nielsen HV, Sakinc T, Henriques-Normark B, Gatermann S et al. Character- ization of a novel murine model of Staphylo- Coccus saprophyticus urinary tract infection reveals roles for ssp and SdrI in virulence. Infect Immun. 2010;78(5):1943-51. doi: 10.1128/IAI.01235-09, PMID 20176795.
Lebreton F, van Schaik W, Sanguinetti M, Posteraro B, Torelli R, Le Bras F et al. AsrR is an oxidative stress sensing regulator modulating Enterococcus faecium opportunistic traits, antimicrobial resistance, and pathogenicity. PLOS Pathog. 2012;8(8):e1002834. doi: 10.1371/journal.ppat.1002834, PMID 22876178.
Leendertse M, Willems RJ, Giebelen IA, van den Pangaart PS, Wiersinga WJ, de Vos AF et al. TLR2-dependent MyD88 signaling contributes to early host defense in murine Enterococcus faecium peritonitis. J Immunol. 2008;180(7):4865-74. doi: 10.4049/jimmunol.180.7.4865, PMID 18354210.
Hjelm E, Lundell-Etherden I, Mårdh PA. Ascending urinary tract infections in rats induced by Staphylococcus saprophyticus and Proteus mirabilis. Acta Pathol Microbiol Immunol Scand B. 1987;95(6):347-50. doi: 10.1111/j.1699-0463.1987.tb03136.x, PMID 3326399.
Alteri CJ, Himpsl SD, Mobley HL. Preferential use of central metabolism in vivo reveals a nutritional basis for polymicrobial infection. PLOS Pathog. 2015;11(1):e1004601. doi: 10.1371/journal.ppat.1004601, PMID 25568946.
Armbruster CE, Smith SN, Yep A, Mobley HL. Increased incidence of urolithiasis and bacteremia during Proteus mirabilis and Providencia stuartii coinfection due to syner- gistic induction of urease activity. J Infect Dis. 2014;209(10):1524-32. doi: 10.1093/infdis/jit663, PMID 24280366.
Tsuchimori N, Hayashi R, Shino A, Yamazaki T, Okonogi K. Enterococcus faecalis aggravates pyelonephritis caused by Pseudomonas aeruginosa in experimental ascending mixed urinary tract infection in mice. Infect Immun. 1994;62(10):4534-41. doi: 10.1128/iai.62.10.4534-4541.1994, PMID 7927719.
Kline KA, Schwartz DJ, Gilbert NM, Hultgren SJ, Lewis AL. Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli. Infect Immun. 2012;80(12):4186-94. doi: 10.1128/IAI.00684-12, PMID 22988014.
Lazar V, Ditu LM, Pircalabioru GG, Gheorghe I, Curutiu C, Holban AM, et al. Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology, and cancer. Front Immunol. 2018;9:1830. doi: 10.3389/fimmu.2018.01830, PMID 30158926.
Delcaru C, Alexandru I, Podgoreanu P, Grosu M, Stavropoulos E, Chifiriuc MC et al. Microbial biofilms in Urinary Tract Infections and Prostatitis: etiology, Pathogenicity, and Combating strategies. Pathogens. 2016 Nov 30;5(4):65. doi: 10.3390/pathogens5040065, PMID 27916925.
Amalaradjou MAR, Venkitanarayanan K. Role of bacterial biofilms in catheter-associated urinary tract infections (CAUTI) and strategies for their control. In: London: IntechOpen; 2013. Recent advances in the field of urinary tract infections [internet] Nelius T, editor [cited Sep 02 2022]. Available from: https://www.intechopen.com/chapters/45345doi. doi: 10.5772/55200.
Anghel I, Grumezescu AM, Holban AM, Ficai A, Anghel AG, Chifiriuc MC. Biohybrid nanostructured iron oxide nanoparticles and Satureja hortensis to prevent fungal biofilm development. Int J Mol Sci. 2013;14(9):18110-23. doi: 10.3390/ijms140918110, PMID 24009022.
Israil AM, Chifiriuc MC. Interbacteriana phenomenon of communication: new concepts in anti-infective therapy. Asclepius; Bucharest, Romania; 2009. p. 110-5.
Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science. 1999;284(5418):1318-22. doi: 10.1126/science.284.5418.1318, PMID 10334980.
Soto SM. Importance of biofilms in urinary tract infections: new therapeutic approaches. Adv Biol. 2014;13:543974.
Donlan RM. Biofilm: microbial life on surface. Emerg Infect Dis. 2002;8(9):881-90. doi: 10.3201/eid0809.020063, PMID 12194761.
Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol. 2002;292(2):107-13. doi: 10.1078/1438-4221-00196, PMID 12195733.
Magdalena L, Ştefania G, Elena E, Ioana I, Alexandra B, Grigore M et al. Silver-titanium dioxide nanocomposites as effective antimicrobial and antibiofilm agents. J Nanopart Res. 2013;16:2203.
Fok CS, Gao X, Lin H, Thomas-White KJ, Mueller ER, Wolfe AJ et al. Urinary symptoms are associated with certain urinary microbes in urogynecologic surgical patients. Int Urogynecol J. 2018;29(12):1765-71. doi: 10.1007/s00192-018-3732-1, PMID 30116843.
Senneby E, Petersson AC, Rasmussen M. Clinical and microbiological features of bacteraemia with Aerococcus urinae. Clin Microbiol Infect. 2012;18(6):546-50. doi: 10.1111/j.1469-0691.2011.03609.x, PMID 21895858.
Johnson MH, Strope SA. Encrusted cystitis. Urology. 2012;79(3):e31-2. doi: 10.1016/j.urology.2011.12.013, PMID 22386439.
Sánchez Hernández J, Mora Peris B, Yagüe Guirao G, Gutiérrez Zufiaurre N, Muñoz Bellido JL, Segovia Hernández M et al. In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum. Int J Antimicrob Agents. 2003;22(5):492-6. doi: 10.1016/s0924-8579(03)00121-3, PMID 14602367.
Schaal KP, Yassin AF, Stackebrandt E. The family Actinomycetaceae: the genera Actinomyces, Actinobaculum, Arcanobacterium, Varibaculum, and Mobiluncus. In: Dworkin M, Falkow S, Rosenberg E, Schleifer K-H, Stackebrandt E, editors. The prokaryotes. 3rd ed. New York: Springer; 2006. p. 430-537.
Cattoir V. Actinobaculum schaalii: review of an emerging uropathogen. J Infect. 2012;64(3):260-7. doi: 10.1016/j.jinf.2011.12.009, PMID 22209960.
Clarke RW, Collins LE, Maskell R. Gardnerella vaginalis as a urinary pathogen. J Infect. 1989;19(2):191-3. doi: 10.1016/s0163-4453(89)92189-0, PMID 2809241.
Sturm AW. Gardnerella vaginalis in infections of the urinary tract. J Infect. 1989;18(1):45-9. doi: 10.1016/s0163-4453(89)93642-6, PMID 2783715.
Lawson PA, Falsen E, Akervall E, Vandamme P, Collins MD. Characterization of some Actinomyces-like isolates from human clinical specimens: reclassification of Actinomyces suis (Soltys and Spratling) as Actinobaculum suis comb. nov. and description of Actinobaculum schaalii sp. nov. Int J Syst Bacteriol. 1997;47(3):899-903. doi: 10.1099/00207713-47-3-899, PMID 9226926.
Stern JA, Hsieh YC, Schaeffer AJ. Residual urine in an elderly female population: novel implications for oral estrogen replacement and impact on recurrent urinary tract infection. J Urol. 2004;171(2 Pt 1):768-70. doi: 10.1097/01.ju.0000107261.64927.b3, PMID 14713807.
Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17(4):259-68. doi: 10.1016/s0924-8579(00)00350-2, PMID 11295405.
Kramer H, Kuffel G, Thomas-White K, Wolfe AJ, Vellanki K, Leehey DJ et al. Diversity of the midstream urine microbiome in adults with chronic kidney disease. Int Urol Nephrol. 2018;50(6):1123-30. doi: 10.1007/s11255-018-1860-7, PMID 29651696.
Andrade-Oliveira V, Foresto-Neto O, Watanabe IKM, Zatz R, Câmara NOS. inflammation in renal diseases: new and old players. Front Pharmacol. 2019;10:1192. doi: 10.3389/fphar.2019.01192, PMID 31649546.
Crespo-Salgado J, Vehaskari VM, Stewart T, Ferris M, Zhang Q, Wang G, et al. Intestinal microbiota in pediatric patients with end stage renal disease: a midwest pediatric nephrology consortium study. Microbiome. 2016;4(1):50. doi: 10.1186/s40168-016-0195-9, PMID 27640125.
Di Iorio BR, Rocchetti MT, De Angelis M, Cosola C, Marzocco S, Di Micco L, et al. Nutritional therapy modulates intestinal microbiota and reduces serum levels of total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease (medika study). J Clin Med. 2019;8(9):1424. doi: 10.3390/jcm8091424, PMID 31510015.
Wang X, Yang S, Li S, Zhao L, Hao Y, Qin J, et al. Aberrant gut microbiota alters host metabolome and impact renal failure in humans and rodents. Gut. 2020;69(12):2131-42. doi: 10.1136/gutjnl-2019-319766.
Wu IW, Lin CY, Chang LC, Lee CC, Chiu CY, Hsu HJ, et al. Gut microbiota as diagnostic tools for mirroring disease progression and circulating nephrotoxic levels in chronic kidney disease: discovery and validation study. Int J Biol Sci. 2020;16(3):420-34. doi: 10.7150/ijbs.37421, PMID 32015679.
Wu JF, Muthusamy A, Al-Ghalith GA, Knights D, Guo B, Wu B et al. Urinary microbiome associated with chronic allograft dysfunction in kidney transplant recipients. Clin Transplant. 2018;32(12):e13436. doi: 10.1111/ctr.13436, PMID 30372560.
Gerges-Knafl, D., Pichler, P., Zimprich, A. et al. The urinary microbiome shows different bacterial genera in renal transplant recipients and non-transplant patients at time of acute kidney injury – a pilot study. BMC Nephrol 21,117 (2020). https://doi.org/10.1186/s12882-020-01773-1
Rani A, Ranjan R, McGee HS, Andropolis KE, Panchal DV, Hajjiri Z et al. Urinary microbiome of kidney transplant patients reveals dysbiosis with potential for antibiotic resistance. Transl Res. 2017;181:59-70. doi: 10.1016/j.trsl.2016.08.008, PMID 27669488.
Fricke WF, Maddox C, Song Y, Bromberg JS. Human microbiota characterization in the course of renal transplantation. Am J Transplant. 2014;14(2):416-27. doi: 10.1111/ajt.12588, PMID 24373208.
Modena BD, Milam R, Harrison F, Cheeseman JA, Abecassis MM, Friedewald JJ et al. Changes in urinary microbiome populations correlate in kidney transplants with interstitial fibrosis and tubular atrophy documented in early surveillance biopsies. Am J Transplant. 2017;17(3):712-23. doi: 10.1111/ajt.14038, PMID 27597148.
Fiorentino M, Pesce F, Schena A, Simone S, Castellano G, Gesualdo L. Updates on urinary tract infections in kidney transplantation. J Nephrol. 2019;32(5):751-61. doi: 10.1007/s40620-019-00585-3, PMID 30689126.
Pesce F, Martino M, Fiorentino M, Rollo T, Simone S, Gallo P et al. Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: A single-center retrospective cohort study. J Nephrol. 2019;32(4):661-8. doi: 10.1007/s40620-019-00591-5, PMID 30701457.
Abbott KC, Swanson SJ, Richter ER, Bohen EM, Agodoa LY, Peters TG et al. Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis. 2004;44(2):353-62. doi: 10.1053/j.ajkd.2004.04.040, PMID 15264195.
Santiago-Rodriguez TM, Ly M, Bonilla N, Pride DT. The human urine virome in association with urinary tract infections. Front Microbiol. 2015;6:14. doi: 10.3389/fmicb.2015.00014, PMID 25667584.
Garretto A, Miller-Ensminger T, Wolfe AJ, Putonti C. Bacteriophages of the lower urinary tract. Nat Rev Urol. 2019;16(7):422-32. doi: 10.1038/s41585-019-0192-4, PMID 31073244.
Divers J, Langefeld CD, Lyles DS, Ma L, Freedman BI. Protective association between JC polyoma viruria and kidney disease. Curr Opin Nephrol Hypertens. 2019;28(1):65-9. doi: 10.1097/MNH.0000000000000464, PMID 30320619.
Sigdel TK, Mercer N, Nandoe S, Nicora CD, Burnum-Johnson K, Qian WJ et al. Urinary virome perturbations in kidney transplantation. Front Med (Lausanne). 2018;5:72. doi: 10.3389/fmed.2018.00072, PMID 29725592.
Lecuit M, Eloit M. The human virome: new tools and concepts. Trends Microbiol. 2013;21(10):510-5. doi: 10.1016/j.tim.2013.07.001, PMID 23906500.
Stern J, Miller G, Li X, Saxena D. Virome and bacteriome: two sides of the same coin. Curr Opin Virol. 2019;37:37-43. doi: 10.1016/j.coviro.2019.05.007, PMID 31177014.
Brennan DC. Introduction: kidney transplantation and viral infections. Semin Nephrol. 2016;36(5):343. doi: 10.1016/j.semnephrol.2016.05.010, PMID 27772618.
Vanichanan J, Udomkarnjananun S, Avihingsanon Y, Jutivorakool K. Common viral infections in kidney transplant recipients. Kidney Res Clin Pract. 2018;37(4):323-37. doi: 10.23876/j.krcp.18.0063, PMID 30619688.
Rossi AP, Anderson KL, Brennan DC. JC polyoma virus and kidney disease. Kidney Int. 2014;85(5):1242. doi: 10.1038/ki.2014.38, PMID 24786885.
Rani A, Ranjan R, McGee HS, Metwally A, Hajjiri Z, Brennan DC et al. A diverse virome in kidney transplant patients contains multiple viral subtypes with distinct polymorphisms. Sci Rep. 2016;6:33327. doi: 10.1038/srep33327, PMID 27633952.
Schreiber PW, Kufner V, Hübel K, Schmutz S, Zagordi O, Kaur A et al. Metagenomic virome sequencing in living donor and recipient kidney transplant pairs revealed JC polyomavirus transmission. Clin Infect Dis. 2019;69(6):987-94. doi: 10.1093/cid/ciy1018, PMID 30508036.
Łusiak-Szelachowska M, Weber-Dąbrowska B, Jończyk-Matysiak E, Wojciechowska R, Górski A. Bacteriophages in the gastrointestinal tract and their implications. Gut Pathog. 2017;9:44. doi: 10.1186/s13099-017-0196-7, PMID 28811841.
Ogilvie LA, Jones BV. The human gut virome: A multifaceted majority. Front Microbiol. 2015;6:918. doi: 10.3389/fmicb.2015.00918, PMID 26441861.
Manrique P, Dills M, Young MJ. The human gut phage community and its implications for health and disease. Viruses. 2017;9(6):141. doi: 10.3390/v9060141, PMID 28594392.
Navarro F, Muniesa M. Phages in the human body. Front Microbiol. 2017;8:566. doi: 10.3389/fmicb.2017.00566, PMID 28421059.
Miller-Ensminger T, Garretto A, Brenner J, Thomas-White K, Zambom A, Wolfe AJ et al. Bacteriophages of the urinary microbiome. J Bacteriol. 2018;200(7):e00738-17. doi: 10.1128/JB.00738-17, PMID 29378882.
Brown-Jaque M, Muniesa M, Navarro F. Bacteriophages in clinical samples can interfere with microbiological diagnostic tools. Sci Rep. 2016;6:33000. doi: 10.1038/srep33000, PMID 27609086.
Sybesma W, Zbinden R, Chanishvili N, Kutateladze M, Chkhotua A, Ujmajuridze A et al. Bacteriophages as potential treatment for urinary tract infections. Front Microbiol. 2016;7:465. doi: 10.3389/fmicb.2016.00465, PMID 27148173.
Ackerman AL, Anger JT, Khalique MU, Ackerman JE, Tang J, Kim J et al. Optimization of DNA extraction from human urinary samples for mycobiome community profiling. PLOS ONE. 2019;14(4):e0210306. doi: 10.1371/journal.pone.0210306, PMID 31022216.
Pearce MM, Hilt EE, Rosenfeld AB, Zilliox MJ, Thomas-White K, Fok C et al. The female urinary microbiome: A comparison of women with and without urgency urinary incontinence. mBio. 2014;5(4):e01283-14. doi: 10.1128/mBio.01283-14, PMID 25006228.
Thomas-White KJ, Hilt EE, Fok C, Pearce MM, Mueller ER, Kliethermes S et al. Incontinence medication response relates to the female urinary microbiota. Int Urogynecol J. 2016;27(5):723-33. doi: 10.1007/s00192-015-2847-x, PMID 26423260.
Nickel JC, Stephens A, Landis JR, Mullins C, van Bokhoven A, Lucia MS et al. Assessment of the lower urinary tract microbiota during symptom flare in women with urologic chronic pelvic pain syndrome: a MAPP network study. J Urol. 2016;195(2):356-62. doi: 10.1016/j.juro.2015.09.075, PMID 26410734.
Fricker AM, Podlesny D, Fricke WF. What is new and relevant for sequencing-based microbiome research? A mini-review. J Adv Res. 2019;19:105-12. doi: 10.1016/j.jare.2019.03.006, PMID 31341676.
Sinclair L, Osman OA, Bertilsson S, Eiler A. Microbial community composition and diversity via 16S rRNA gene amplicons: evaluating the Illumina platform. PLOS ONE. 2015;10(2):e0116955. doi: 10.1371/journal.pone.0116955, PMID 25647581.
Smirnov KS, Maier TV, Walker A, Heinzmann SS, Forcisi S, Martinez I, et al. Challenges of metabolomics in human gut microbiota research. Int J Med Microbiol. 2016;306(5):266-79. doi: 10.1016/j.ijmm.2016.03.006, PMID 27012595.
Human Microbiome Project Consortium. A framework for human microbiome research. Nature. 2012;486(7402):215-21. doi: 10.1038/nature11209, PMID 22699610.
Thomas-White K, Forster SC, Kumar N, Van Kuiken M, Putonti C, Stares MD et al. Culturing of female bladder bacteria reveals an interconnected urogenital microbiota. Nat Commun. 2018;9(1):1557. doi: 10.1038/s41467-018-03968-5, PMID 29674608.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Aishwarya J Ramalingam, Sameena Khan, Manonmoney J, Archana R
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
